Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico

Open Access

Peer-reviewed

Research Article

Yared Santa-Ana-Tellez,

Affiliation WHO Collaborating Centre for Pharmaceutical Policy & Regulation, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands
⨯
Aukje K. Mantel-Teeuwisse,

Affiliation WHO Collaborating Centre for Pharmaceutical Policy & Regulation, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands
⨯
Anahi Dreser,

Affiliation Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico
⨯
Hubert G. M. Leufkens,

Affiliation WHO Collaborating Centre for Pharmaceutical Policy & Regulation, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands
⨯
Veronika J. Wirtz

* E-mail: vwirtz@bu.edu

Affiliations Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico, Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

Antibiotics
Is the Subject Area "Antibiotics" applicable to this article?

Thanks for your feedback.
Brazil
Is the Subject Area "Brazil" applicable to this article?

Thanks for your feedback.
Antibiotic resistance
Is the Subject Area "Antibiotic resistance" applicable to this article?

Thanks for your feedback.
Mexico
Is the Subject Area "Mexico" applicable to this article?

Thanks for your feedback.
Drug regulation
Is the Subject Area "Drug regulation" applicable to this article?

Thanks for your feedback.
Penicillin
Is the Subject Area "Penicillin" applicable to this article?

Thanks for your feedback.
Antihypertensives
Is the Subject Area "Antihypertensives" applicable to this article?

Thanks for your feedback.
Sulfonamide
Is the Subject Area "Sulfonamide" applicable to this article?

Thanks for your feedback.